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HEALTH CARE DECISIONS IN THE NEW ERA
OF HEALTH CARE REFORM: AN OVERVIEW*
JOAN

H. KRAUSE* & RICHARD S. SAVER*

"Some problems are so complex that you have to be highly
intelligent and well informed just to be undecided about them."
- Laurence J. Peter, Peter'sAlmanac.'

Peter's wry observation, while not specifically about health care,
aptly captures this symposium's key themes. This symposium
considers decision-making challenges in health care. The subject is
timely, with the push to improve decision making as part of health
care reform, and yet also timeless.
Centuries ago, the famous medieval physician and philosopher
Maimonides observed that "the risk of a wrong decision is preferable
to the terror of indecision."2 Several decades ago, renowned
sociologist Ren6e Fox conducted seminal studies documenting how
physicians struggle with uncertainty throughout their professional
training and medical practice.3 Fox identified three broad categories
of uncertainty that complicate health care: the difficulty in mastering
vast sums of medical knowledge; the limitations of current medical
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1. LAURENCE J. PETER, PETER'S ALMANAC (1982), quoted in LIBRARY OF
CONGRESS, RESPECTFULLY QUOTED: A DICTIONARY OF QUOTATIONS REQUESTED
FROM THE CONGRESSIONAL RESEARCH SERVICE 78 (Suzy Platt ed., 1989).

2. Quoted in David Gurwitz & Jeantine E. Lunshof, Personalized Participatory
Medicine: Sharing Knowledge and Uncertainty, 3 GENOME MED. 69, 69 (2011), available at
http://genomemedicine.com/content/pdflgm285.pdf.
3. See RENIE C. FOX, EXPERIMENT PERILOUS: PHYSICIANS

AND PATIENTS

FACING THE UNKNOWN 28-39 (1959); Ren6e C. Fox, Training For Uncertainty, in THE
STUDENT PHYSICIAN: INTRODUCTORY STUDIES IN THE SOCIOLOGY OF MEDICAL

EDUCATION 207, 207-41 (Robert K. Merton et al. eds., 1957).
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knowledge itself; and problems physicians face in distinguishing
between their own personal ignorance and the imperfect current state
of medical science. Fox noted the paradox that "our great ...
progress in medical science and technology has helped to reveal how
ignorant, bewildered, and mistaken we still are in many ways about
health and illness, life and death."'
Decades after Fox's groundbreaking work, physician David
Eddy, in a widely cited article published in 1984, connected the
critical role of uncertainty to significant health policy concerns, such
as the wide variation in the way physicians practice medicine. Eddy
observed that a myriad of factors make health care decisions so
difficult and seemingly discordant:
Uncertainty creeps into medical practice through every pore.
Whether a physician is defining a disease, making a diagnosis,
selecting a procedure, observing outcomes, assessing
probabilities, assigning preferences, or putting it all together, he
is walking on very slippery terrain. It is difficult for
nonphysicians, and for many physicians, to appreciate how
complex these tasks are, how poorly we understand them, and
how easy it is for honest people to come to different
conclusions.'
The point is that decision making in health care, while everchallenging and of serious concern today for health policy, has always
been difficult and often suboptimal. Despite their aura of competent
precision rooted in scientific training, physicians regularly grapple
with incertitude, doubt, and chance. Indeed, medicine, at its core, is a
profession rife with uncertainty.' Among other reasons, the multiple
treatment pathways that are possible for a particular condition,
combined with how patients respond differently to the same
intervention, and the difficulty in measuring and valuing outcomes,
routinely present decision-making challenges for physicians in clinical
practice.
The decision-making difficulties are not limited, however, to
health care providers. On the other side of the treatment relationship,
patients regularly struggle with charting the course of their medical
4. Fox, TrainingFor Uncertainty,supra note 3, at 208-09.
5. Ren6e C. Fox, The Evolution of Medical Uncertainty, 58 MILBANK MEMORIAL
FuND Q. HEALTH & SOC'Y 1, 1 (1980).
6. See David M. Eddy, Variations in Physician Practice: The Role of Uncertainty,
HEALTH AFF., May 1984, at 74, 75.
7. Id.
8. See JEROME GROOPMAN, How DOCTORS THINK 151-52 (2008).
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care. Countless narratives by patients and their family members
describe the crippling and frustrating process of making health care
decisions. One recent noteworthy addition is Pulitzer Prize winning
reporter Amanda Bennett's 2012 book, The Cost of Hope.9 In this
memoir, Bennett details her husband's fight with and eventual death
from kidney cancer. She poignantly describes how the "hundreds of
decisions we made over seven years ... illustrate the impossible

calculus at the core of life, of love of family, and of the U.S. health
care debate."o The bills for her husband's care totaled $618,616,
almost two-thirds of which was spent for care during his final two
years, and much of which was spent on treatments that she still is not
sure extended his life." Bennett laments the health care system's
opacity and the troubling uncertainty that remains despite all the
hardships endured by her family:
And what can we do about a system that is so maddeningly
complex to navigate? One that took days, weeks, months, even
whole years of our lives to figure out? One that leaves me, even
today, four years after Terence's death, not entirely sure we did
the right thing? Why was this system designed for the doctors,
hospitals, laboratories, and technicians and not for Terence and
me?12
As Bennett's memoir illustrates, patients following the many
paths and pitfalls of the health care system must make countless
difficult decisions that implicate wide-ranging considerations,
including of science, emotion, and cost.
Moving one level up from doctors and patients, other key
stakeholders in the health care system consistently confront decisionmaking problems as well. Health care payers (insurers, employers,
etc.) have considerable difficulty deciding which interventions to
cover and which to exclude as the marginal benefit of certain
treatments often remains unclear. For example, consider the recent
outcry over the Medicare program's decision to limit reimbursement
for amyloid brain scans for diagnosing Alzheimer's disease, despite
pleas from patient groups that the scans have important value
because the underlying disease has few proven therapeutic
interventions." Large networks of providers, such as accountable care
9. AMANDA BENNETT, THE COST OF HOPE (2012).

10. Id. at 5.
11. Id.
12. Id. at 223.

13. See Decision Memo for Beta Amyloid Positron Emission Tomography in
Dementia and Neurodegenerative Disease (CAG-00431N), CENTERS FOR MEDICARE &
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organizations ("ACOs"), also run into decision-making quandaries.
In trying to coordinate care and control costs within their provider
networks, ACOs must decide how best to implement standardized
policies affecting large groups of patients with different needs.
Likewise, ACOs must choose between policies that negatively impact
certain network providers (such as reduced income) more than
others. 4 Decision-making challenges also reach the level of health
care regulators. Health care agencies' regulatory choices have become
all the more complex and confounding due to rapid information flow
concerning medical treatments and an ever-expanding number of
measures deployed to assess health outcomes and quality."
Why does decision making remain so difficult when it comes to
health care? To start, the quantity and complexity of clinical
information presents cognition challenges not only for patientsl 6 but
also for providers." But the decision-making difficulties go deeper
than just the fact that clinical information can be quite complicated.
Decision-making problems pervade health care for many additional
reasons, many of which our symposium authors explore further.
These include: (1) treatment decisions can be emotionally charged,
involving high-stakes consequences of life and death; (2) the lack of a
solid evidence base as to how many commonly offered treatments
compare to each other;'" (3) important treatment decisions may not
be answerable by clinical expertise alone, but instead depend
critically on the individual patient's personal values and preferences,
MEDICAID SERVICES (Sept. 27, 2013), http://www.cms.gov/medicare-coverage-database

/shared/handlers/highwire.ashx?url=http://www.cms.gov/medicare-coverage-database
details/nca-decision-memo.aspx@@@NCAld$$$265&session=whzd4i552jssnrnixrroz3mx
&kq=1506488529; Judith Graham, Decision Casts Doubt on Brain Scans for Alzheimer's,
NEW OLD AGE BLOG (Aug. 1, 2013, 5:00 AM), http://newoldage.blogs.nytimes.com
/2013/08/01/doubt-on-brain-scans-for-alzheimers/.
14. See Timothy G. Ferris, Building an Accountable Care Organization,HARV. Bus.
REV. BLOG NETWORK (Sept. 25, 2013, 1:00 PM), http://blogs.hbr.org/2013/09/building-anaccountable-care-organization/.
15. See Kristin Madison, Regulating Health Care Quality in an Information Age, 40
U.C. DAVIS L. REV. 1577, 1579-81 (2007).
16. See, e.g., JULIA JAMES, HEALTH AFFAIRS, PatientEngagement 1 (2013), available
at http://healthaffairs.org/healthpolicybriefs/brief-pdfs/healthpolicybriefL86.pdf.
17. See, e.g., Madison, supra note 15, at 158-83.
18. See Richard S. Saver, Health Care Reform's Wild Card: The Uncertain
Effectiveness of Comparative Effectiveness Research, 159 U. PA. L. REV. 2147, 2170-75
(2011).
19. See Jaime Staples King & Benjamin W. Moulton, Rethinking Informed Consent:
The Case for Shared Medical Decision-Making, 32 AM. J.L. & MED. 429, 448 (2006)
("[E]ven if physicians agreed on a standard of care, for some conditions there is no single
standard treatment appropriate for all individuals, indicating that patient values and
preferences are integral to choosing the best treatment option.").
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which can be highly variable and context dependent; (4) severe
information gaps as to cost and quality that hamper not only patients,
but payers, providers, and regulators of health care; (5) the health
care market largely depends on third-party payment, which
introduces agency costs, moral hazard, and additional complexities
that can lead to suboptimal consumption decisions concerning health
care services;20 (6) the true value of many health care treatments is
not easily answerable or quantifiable, especially for treatments that
offer some modest improvement in therapeutic outcome but at high
marginal cost;2 1 (7) it remains difficult to spell out, as a matter of law
via standard contract or statutory terms, what services are necessary
and should be covered by health care financing and what can be
excluded as unnecessary;22 and (8) despite the increased rhetoric
about and policy push to empower patients as consumers, insights
from behavioral economics and psychology suggest patients may be
poorly predisposed to perform this role and the decisions they have to
make occur under very adverse conditions for quality decision
making.23
Yet we are now living in an exciting time of health care reforma new era that, according to some optimistic accounts, will radically
change health care decisions on many levels. The historic Patient
Protection and Affordable Care Act ("Affordable Care Act" or
"ACA") 24 includes many reform initiatives aimed at improving health
care decision-making. For example, the Affordable Care Act
encourages the creation of ACOs that will share information and

20. See, e.g., Clark C. Havighurst & Barak D. Richman, Who Pays? Who Benefits?
Unfairness in American Health Care, 25 NOTRE DAME J.L. ETHICS & PUB. POL'Y 493,
506-07 (2011).
21. See, e.g., Daniel Callahan, The Fine Line Between Waste and Marginal Benefits,
HEALTH CARE COST MONITOR, http://healthcarecostmonitor.thehastingscenter.org
/daniel-callahan/the-fine-line-between-waste-and-marginal-benefits/ (last visited May 7,
2014).
22. See, e.g., Ana I. Balsa et al., Clinical Uncertainty and Healthcare Disparities, 29
AM. J.L. & MED. 203, 205 (2003) (observing the great degree of clinical discretion in
medical practice and how "[n]either insurance contracts nor ethical and legal rules do a
great deal to narrow the resulting clinical discretion."); Clark C. Havighurst, The
Professional Paradigmof Medical Care: Obstacle to Decentralization,30 JURIMETRICS J.
415, 425 (1990) ("[P]ayers are essentially locked into underwriting all care meeting
professional standards.").
23. See generally Carl E. Schneider & Mark A. Hall, The PatientLife: Can Consumers
Direct Health Care?, 35 AM. J.L. & MED. 7 (2009) (assessing the role of consumerism in
health policy).
24. Patient Protection and Affordable Care Act, Pub. L. No. 111-148, 124 Stat. 119
(2010).
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coordinate care among integrated networks of providers25 and
establishes insurance exchanges where patients can choose between
health plans offering the same essential benefits, that are compared in
standardized formats and that follow uniform enrollment
procedures. 26 The Affordable Care Act also fosters the development
of shared decision making between patients and providers 27 and
develops a more comprehensive evidence base through more robust
support of comparative effectiveness research.28
A key consideration of this symposium is whether all these
changes and many others occurring in the new era of health care
reform (which includes, of course, more than just the Affordable Care
Act) can meaningfully address the decision-making difficulties that
continually hamper the health care system. Are law and policy
helping in this regard or having negligible or even counterproductive
impact? How are law and policy shaping the likely future direction of
important health care decisions?
The topic is quite timely with the Affordable Care Act's
implementation underway. But it is also vitally important because
concern about and attention to decision making is a key piece of the
ongoing debates over health care reform. With the Affordable Care
Act's rollout, very divergent views are emerging about the nature and
role of decision making in the health care system. For example,
consider the new insurance exchanges. Putting aside the separate
controversies surrounding the functionality of the HealthCare.gov
website,29 media reports and public commentary have yielded vastly
different narratives about how patients will fare, even assuming the
enrollment system has no technical snafus, in choosing health plans
on the exchanges. According to a story in the Washington Post,
navigators working to help formerly uninsured patients obtain
coverage on the exchanges face a "daunting" and "herculean" task in
assisting "vast numbers [of patients] who are confused by the myriad
25. See id. § 3022, 42 U.S.C. § 1395jjj (2012).
26. See id. § 1311, 42 U.S.C. § 18031.
27. See id. § 3506, 42 U.S.C. § 299b-36.
28. See id. § 6301, 42 U.S.C. § 1320e.
29. Healthcare.gov is the website for the Health Insurance Marketplace, the federally
run insurance exchange available in states that have not elected to operate their own
insurance exchanges. See Ctrs. for Medicare & Medicaid Servs., Marketplace Overview,
(last
https://www.healthcare.gov/health-insurance-marketplace/
HEALTHCARE.GOV,
visited May 7, 2014). Numerous technical problems with the website have hampered the
enrollment process. See Robert Pear & Reed Abelson, Insurers Claim Health Website is
Still Flawed, N.Y. TIMES (Dec. 1, 2013), http://www.nytimes.com/2013/12/02/business
/white-house-praises-gains-on-health-site.html.
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choices."3 0 This contrasts with an Associated Press ("AP") story
about multi-state employer Walgreen moving many of its employees
to a private insurance exchange, modeled after the new government
run exchanges. The AP report quoted Aon Hewitt executive Ken
Sperling as saying that it was not a big deal for patients to choose a
health plan: "It's a bit more involved than buying a plane ticket, but I
don't think it's more involved than buying a TV."3 1 Clearly, views
about the decisions on the insurance exchanges are so far apart that
there is not even a common understanding about the decision-making
process itself, what's at stake, and the larger implications for health
policy. Such confusion about, and sometimes inattention to, key
decision-making issues in the health care system as it undergoes
reform demonstrate the need for further scholarly examination.
Our symposium authors ably respond to this challenge, tackling
the subject from interdisciplinary perspectives and in a nuanced way,
eschewing pat explanations. They find considerable promise in some
aspects of the Affordable Care Act and other reforms, yet they also
identify key limitations and question whether decision making will
become all the more complex and daunting in the new era of health
care reform. They offer a comprehensive picture of the decisionmaking challenges that arise throughout the health care system. The
articles are organized to address decision making at three different
levels: (1) decisions by patients, (2) financial decisions regarding
health care, and (3) the decisions made by government entities
exercising a regulatory role.
Our first group of articles is designed around the theme of
Patient Decision Making: Birth, Death, and Daily Health. The

grouping reflects the idea that, for many of us, the prototypical health
care decision occurs in the clinical context and involves medical
treatment or at least some aspect of a patient's overall health. Some
of these decisions are the momentous, high-stakes choices often
profiled in the popular press, such as the question of whether to
withdraw medical interventions that are keeping a patient alive.
30. N.C. Aizenman, For Insurance Exchanges, States Need 'Navigators'-andHiring
Them is a Huge Task, WASH. POST (Feb. 4, 2013), http://articies.washingtonpost.com
/2013-02-04/national/36743424_1 insurance-exchanges-navigators-health-insurance.
31. Tom Murphy, Walgreen Health Plans Go Private, CHARLOTTE OBSERVER (Sept.
18, 2013), http://www.charlotteobserver.com/2013/09/18/4324233/walgreen-health-plansgo-private.html#.UnrL27Eo670.
32. See, e.g., Cruzan v. Dir., Missouri Dep't of Health, 497 U.S. 261, 292 (1990)
(holding that Missouri could require clear and convincing evidence of an incompetent
patient's wishes to withdraw life-sustaining treatment).
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Other decisions are more incremental, such as whether to undergo a
test designed to provide additional information that might, as a result,
require a more difficult decision in the future-such as the choice of
whether to undergo prenatal testing that may reveal information
about the developing fetus.33 And still other decisions appear to be so
mundane, and are made so often, that we all but cease to recognize
them as health care decisions at all-such as what to eat, whether to
go to the gym, or whether to light up another cigarette.3 4
Many of these clinical decisions take place in private, made by
the patient and family members in consultation with doctors and
other health care professionals. In these situations, the legal system
has focused on ensuring that patients have both the information and
the opportunities to make these treatment decisions and on creating
procedures designed to minimize conflicts that might arise among
decision makers." Occasionally, however, these decisions play out on
a very public stage, such as the disputes over end-of-life care for
Karen Quinlan, Nancy Cruzan, and, most recently, Terri Schiavo.36 In
other situations the public stage is a political one, with legislators
seeking to mandate the provision of specific information before
patients can elect certain medical treatments (such as new laws
requiring pregnant women to receive mandatory ultrasounds prior to
consenting to abortion)." Regardless of personal views on the merits
of these disputes, it is clear that these intimate health care decisions
may be altered irrevocably when they are forced to take place in a
public context. Moreover, it is far from certain that simply presenting
patients (and doctors) with more information-whether from the
scientific literature, the hospital legal department, or the legislature-

33. See, e.g., Am. College of Obstetricians and Gynecologists Comm. on Genetics &
Soc'y for Maternal-Fetal Med., The Use of Chromosomal MicroarrayAnalysis in Prenatal
Diagnosis, COMMITTEE OPINION, No. 581, 1 (Dec. 2013), http://www.acog.org//media/Committee%200pinions/Committee%20on%20Genetics/co58l.pdf?dmc=1&ts=20
140126T1021504634 (offering "recommendations regarding the application of
chromosomal microarray technology in the prenatal setting").
34. Cf 42 U.S.C. § 300gg-17(b) (2012) (describing the potential scope of wellness and
prevention programs).
35. See, e.g., Right to Natural Death; Brain Death, N.C. GEN. STAT. §§ 90-329 to -324
(2013).
36. See Sandra H. Johnson, Quinlan and Cruzan: Beyond the Symbols, in HEALTH
LAW AND BIOETHICS: CASES IN CONTEXT 53,53 (Sandra H. Johnson et al. eds., 2009).
37. See, e.g., Woman's Right to Know Act, N.C. GEN. STAT. § 90-21.85 (2013)
(mandating that pregnant women undergo a physician-administered ultrasound before
obtaining an abortion), invalidated by Stuart v. Loomis, 2014 U.S. Dist. LEXIS 6194
(M.D.N.C. Jan. 17, 2014).
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automatically leads to better decisions. In short, bombarding people
with information about their health care choices, from ever-changing
dietary or screening recommendations to detailed advanced directive
forms, may just as easily lead to paralysis as to perspicacity.
To the extent the law seeks to improve these types of decision
making, the papers in this first group must consider whether the law is
responsive to the concrete difficulties faced by patients and their
caregivers. Professor Lois Shepherd from the University of Virginia
explores some of these issues in The End of End of Life Law."

Noting that the legal system has, over time, developed complex rules
that treat end-of-life decisions differently than other important
medical decisions, Professor Shepherd argues that end-of-life
decisions instead "should be approached like other important
questions about medical care-with consideration to patients' wishes,
values, interests, and relationships, and without special laws, special
burdens of proof, or unique requirements for documentation."40
Shifting the focus to more common health care choices, Dr. David
Orentlicher of the Indiana University Robert H. McKinney School of
Law highlights problems in our approach to daily wellness decisions
in Health Care Reform and Efforts to Encourage Healthy Choices by

Individuals.4 1 Dr. Orentlicher is particularly critical of the Affordable
Care Act's attempts to improve individual wellness decisions through
menu labeling requirements and employer wellness programs. He
argues that the lack of empirical evidence as to which strategies work
may have the unintended effect of discouraging healthy choices and
undermining the goal of improving access to health care. 42 These
articles illustrate the dangers inherent in developing static rules that
are designed to improve patient decision making, however wellintentioned those rules may be.43

38. See, e.g., Harlan M. Krumholz, Informed Consent to Promote Patient-Centered
Care, 303 JAMA 1190, 1190 (2010) (concluding with regard to the legal requirements of
informed consent that "current efforts to inform patients are inadequate," the information
distributed "ha[s] limited educational value," and many patients do not read the disclosure
forms and "misunderstand the benefits and risks" of their treatments).
39. See generally Lois Shepherd, The End of End of Life Law, 92 N.C. L. REV. 1693
(2014) (discussing the rules and changes in end of life law).
40. Id. at 1696.
41. See David Orentlicher, Health Care Reform and Efforts to Encourage Healthy
Choices by Individuals,92 N.C. L. REV. 1637,1657 (2014).
42. Id. at 1639-42.
43. The live symposium also featured a talk on reproductive decision making. Dr.
Anne Drapkin Lyerly, Assoc. Dir. of the Ctr. for Bioethics & Assoc. Professor of Soc.
Med., Univ. of N.C. Sch. of Med., Address at the University of North Carolina Law
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Our second group of articles, designed around the theme of
Financial Decision Making: Cost and Coverage, recognizes the core

financial component of many health care decisions. For patients,
financial considerations inform not only the choice of insurance, but
in many cases the choice of treatment. While the Affordable Care Act
sought to make it easier for individuals to compare health insurance
policies on the insurance exchanges by mandating a standardized
summary of benefits and costs," there is no guarantee that patients
will be able to use that information to make wise choices. Financial
decisions loom large for insurers as well, who must decide whether to
participate on a state insurance exchange and, if so, which plans to
offer.45 State governments also must make a range of decisions with
implications for health care costs and insurance coverage, most
notably whether or not to expand the existing Medicaid program, but
also decisions regarding whether to operate a state-based insurance
exchange and how to choose a benchmark health plan for the state.46
The papers in this group address the financial implications of
health care decisions for both consumers and state governments. In
Can Patients in the U.S. Become Savvy Health Care Consumers?, Dr.

Peter Ubel of Duke University questions whether efforts to shift
health care costs to patients have improved patients' health care
decisions.47 While acknowledging that forcing patients to have "skin
in the game" ultimately may decrease health care expenditures,4 Dr.
Ubel identifies key clinical barriers that nevertheless prevent patients
from becoming the types of educated consumers they are in other
Review Symposium: Information and Autonomy in Reproductive Decisionmaking (Oct. 4,
2013).
44. See Patient Protection and Affordable Care Act, sec. 2715, 42 U.S.C. § 300gg-15
(2012) ("Development and utilization of uniform explanations of coverage documents and
standardized definitions").
45. See, e.g., Reed Abelson, Choice of Health Plans to Vary Sharply from State to
State, N.Y. TIMES (June 16, 2013), http://www.nytimes.com/2013/06/17/health/choice-ofhealth-plans-to-vary-sharply-from-state-to-state.html?-r=0 (describing range of insurers
and products available in different states).
46. See, e.g., Nat'l Fed'n of Indep. Bus. v. Sebelius, 132 S. Ct. 2566, 2607 (2012)
(holding that Medicaid expansion must be voluntary); Ctrs. for Medicare & Medicaid
Servs., North Carolina EHB Benchmark Plan, CENTERS FOR MEDICARE & MEDICAID
SERVICES,
http://www.cms.gov/CCIIO/Resources/Data-Resources/Downloads/northcarolina-ehb-benchmark-plan.pdf (last visited May 7, 2014); Ctrs. for Medicare &
Medicaid Servs., What is the Marketplace in My State?, HEALTHCARE.GOV,
https://www.healthcare.gov/what-is-the-marketplace-in-my-state/ (last visited May 7, 2014)
(identifying whether there is a state exchange or whether residents should use the federal
marketplace).
47. See Peter Ubel, Can Patients in the U.S. Become Savvy Health Care Consumers?,
92 N.C. L. REV. 1749, 1750 (2014).
48. Id.
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settings, including: a lack of price information; too little time to
consider the available information when making urgent health care
decisions; the difficulty of fitting discussions about the cost of care
into the traditional model of the doctor-patient relationship; and the
mismatch between financial incentives and clinical benefits for many
health care services.49 Unless these problems are addressed, Dr. Ubel
argues that patients will face higher costs without a concomitant
improvement in their ability to make decisions about their medical
treatments.o Professor Allison Hoffman of the University of
California Los Angeles School of Law expands on the theme of
patients' financial decisions in Insurance and FinancialSecurity After
the Affordable Care Act." Professor Hoffman focuses on the degree

to which the protections enacted by the Affordable Care Act will
reduce "financial insecurity" due to health care costs for different
groups of patients.52 While acknowledging that the law will, to some
extent, reduce financial insecurity for each group, Professor Hoffman
concludes that even after health care reform, patients will face
significant variations in their exposure to health care expenses.5 3
Professor Mark Hall of Wake Forest University shifts the focus
to state financial decision making in States' Decisions Not to Expand

Medicaid.54 Professor Hall focuses on two of the major decisions
required of states under the Affordable Care Act: (1) whether to
create a state-based insurance exchange, a decision he argues has
been made on counterintuitive political grounds; and (2) whether to
expand Medicaid, a decision he argues should be based on financial
considerations that weigh heavily in favor of expansion." Examining
and rejecting the common rationales for not expanding Medicaidchiefly, concerns for patient dependency and the expense of the
program-Professor Hall argues that the states that have refused
expansion appear to be acting instead out of political expediency or
ideology.56 In Professor Hall's view, such "spiteful refusal of federal
49. See generally id. (arguing about the costs, benefits, and challenges surrounding
increased patient involvement).
50. Id. at 1784-85.
51. See generally Allison K. Hoffman, Insurance and Financial Security After the
Affordable Care Act, 92 N.C. L. REV. 1482 (2014) (discussing how the Affordable Care
Act conceives of financial security and its varied impacts on different groups).
52. Id. at 1484.
53. See id. at 1533.
54. See generally Mark A. Hall, States' Decisions Not to Expand Medicaid, 92 N.C. L.
REV. 1459 (2014) (discussing some states' opposition to expanding Medicaid and the
rationales provided in support for these choices).
55. Id. at 1459-63.
56. Id. at 1477.
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funds in order to undermine the ACA is at least callous, if not
reprehensible."" In short, it is clear that health care reform has not
resolved-and indeed may have exacerbated-many of the structural
and political barriers to rational financial health care decision making.
The third and final grouping of articles, Regulatory Decision
Making: The Government's Role in Information and Quality Control,

considers larger governmental oversight and regulatory design
decisions in the health care system. While the role of major legislative
decisions that shape the health care system-such as the passage of
the Affordable Care Act itself 58 -may be apparent to most observers,
the government's extensive role in operational decisions affects the
provision of health care on an ongoing, if more mundane, basis. From
the organization of the governmental agencies charged with
implementing the Affordable Care Act to standards for the collection
and analysis of data, regulatory decisions have implications for
virtually every aspect of health care.59
The papers in this group address this governmental role,
particularly as it relates to information and quality control. Dr. Aaron
Kesselheim of Harvard Medical School and Professor Michelle Mello
of the Harvard School of Public Health address one aspect of this
problem-government regulation of the promotion of pharmaceutical
products-in Prospectsfor Regulation of Off-Label Drug Promotion
in an Era of Expanding Commercial Speech Protection.' The authors

focus on the implications of a recent First Amendment case in the
Second Circuit, United States v. Caronia,6 1 for the ability of the Food
and Drug Administration to restrict a manufacturer's promotion of
products "off-label," beyond the uses for which the drugs are
approved.62 Arguing that "years of experience with industry
marketing practices leading to dangerous, non-evidence-based offlabel uses of medical products justify the need for regulation in this
57. See id. at 1476-77.
58. Patient Protection and Affordable Care Act, Pub. L. No. 111-148, 124 Stat. 119
(2010).
59. See, e.g., 42 U.S.C. §§ 1320d-1320d-9 (2012) (requiring standards for the electronic
transmission of health information); The Centerfor Consumer Information & Insurance
Oversight: Ensuring the Affordable Care Act Serves the American People, CENTERS FOR
MEDICARE & MEDICAID SERVICES, http://cms.gov/cciio/index.html (last visited May 7,
2014) (implementing provisions of Affordable Care Act).
60. See generally Aaron Kesselheim & Michelle M. Mello, Prospectsfor Regulation of
Off-Label Drug Promotion in an Era of Expanding Commercial Speech Protection, 92
N.C. L. Rev. 1539 (2014) (addressing the intersection of the First Amendment and FDA
regulation of pharmaceuticals).
61. 703 F.3d 149 (2d Cir. 2012).
62. Kesselheim & Mello, supranote 60, at 1543.
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arena,"63 Kesselheim and Mello seek to identify strategies that would
permit the government to restrict dangerous behavior without
running afoul of First Amendment rights to free speech.'
Professor Kristen Madison, Professor of Law and Health
Sciences at Northeastern University, addresses the federal
government's growing role with regard to the collection and use of
health care data in her essay, Health Regulators as Data Stewards.65
Rather than serving merely as a repository for such data, Professor
Madison argues that the federal government in essence functions as a
"data steward," managing this information and thereby influencing
the type of information that is available to health care decision
makers.66 Professor Madison argues that the government must work
to ensure that this data is better used to improve regulatory decision
making, particularly by creating "an evidence base for regulatory and
programmatic interventions."6 7
Finally, in Private Certifiers and Deputies in American Health

Care, Professor Frank Pasquale of the University of Maryland Francis
King Carey School of Law turns to the government's role in setting
standards for a variety of health care items and services, with a
particular focus on the recent practice of outsourcing such decisions
to private organizations.68 Professor Pasquale examines two
outsourcing models: private certification, in which private firms
certify that a technology or service meets applicable standards, and
deputization, in which private firms are charged with disciplining
health care providers who fail to meet those standards.6 9 While noting
that these approaches may offer a more flexible form of
administrative governance in complex and rapidly changing fields
such as health care, Professor Pasquale also identifies the very real
potential for abuse of public programs by private entities. 0 Professor
Pasquale ends by urging a more "seamless integration of clinical

63. Id. at 1599.
64. Id. at 1599-60.
65. See generally Kristin Madison, Health Regulators as Data Stewards, 92 N.C. L.
REV. 1605 (2014) (addressing the intersection of big data, federal regulation, and health
care).
66. Id. at 1607-08.
67. Id. at 1609.
68. See generally Frank A. Pasquale, Private Certifiers and Deputies in American
Health Care, 92 N.C. L. REV. 1661 (2014) (addressing the interaction between
government's regulatory role in setting standards and the on-going outsourcing
phenomenon).
69. Id. at 1662.
70. Id. at 1662-63.
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decision support, revenue cycle management, and fraud detection""
if public-private partnerships are to serve their intended purpose.
Overall, these papers ably illustrate the complexity of regulatory
decision making in a post-health care reform world.
The perils of decision making, and the promise of improvement,
have been well documented by researchers such as Dan Ariely:
[W]e are not only irrational, but predictably irrational-[] our
irrationality happens the same way, again and again. Whether
we are acting as consumers, businesspeople, or policy makers,
understanding how we are predictably irrational provides a
starting point for improving our decision making and changing
the way we live for the better.7 2
These perils are only magnified when the decisions at issue
concern health care, where faulty choices may affect the health and
well-being (not to mention the livelihood) of myriad patients and
health care providers. Decisions pervade every aspect of health
care-from the mundane to the momentous, from the clinic to the
courtroom, for everyone from patients to policymakers. The
participants in this symposium seek to illuminate the pressures on,
and the potential for, productive decisions as the health care system
undergoes transition. In our view, they admirably succeed in
advancing the academic conversation and larger understanding about
the key role of decision making in the new era of health care reform.

71. Id. at 1690.
72. DAN ARIELY, PREDICTABLY IRRATIONAL: THE HIDDEN FORCES THAT SHAPE
OUR DECISIONS xx (1st ed. 2008).

